2010
|
Sign up to set email alerts
Local Administration of 1% Ubretid in the Handling of Glaucoma, Myasthenia Gravis and Esotropia
Search citation statements
Order By: Relevance
Paper Sections
Select...
8
2
0
0
Citation Types
0
5
0
0
Year Published
Range
1972
19722021
2021Publication Types
Select...
8
2
Relationship
0
10
Authors
Journals
Cited by 10 publications
(5 citation statements)
References 11 publications
0
5
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1). Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder.…”
mentioning
confidence: 99%
“…Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder. [4][5][6][7][8] The effectiveness and usefulness of distigmine for underactive bladder treatment have been shown in many clinical studies.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1). Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder.…”
mentioning
confidence: 99%
“…Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder. [4][5][6][7][8] The effectiveness and usefulness of distigmine for underactive bladder treatment have been shown in many clinical studies.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…It and other carbamate ChE inhibitors have been used to treat myasthenia gravis in Asia, the Middle East, and Europe. [2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968.…”
Section: Introduction
mentioning
confidence: 99%
“…[2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968. It was reported that distigmine has a therapeutic effect on neurogenically underactive bladder caused by surgery, spinal cord injury, and chronic diseases such as diabetes.…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Distigmine bromide (distigmine) is a carbamate group reversible cholinesterase (ChE) inhibitor that was chemically synthetized by Schmid et al in the 1950s [1][2][3] . Although the primary clinical indication for distigmine is its involvement in the treatment of myasthenia gravis [4][5][6] , in Japan, it is also used to treat glaucoma [7][8][9][10] and underactive bladder [11][12][13][14][15][16][17] .…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1). Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder.…”
mentioning
confidence: 99%
“…Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder. [4][5][6][7][8] The effectiveness and usefulness of distigmine for underactive bladder treatment have been shown in many clinical studies.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…It and other carbamate ChE inhibitors have been used to treat myasthenia gravis in Asia, the Middle East, and Europe. [2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968.…”
Section: Introduction
mentioning
confidence: 99%
“…[2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968. It was reported that distigmine has a therapeutic effect on neurogenically underactive bladder caused by surgery, spinal cord injury, and chronic diseases such as diabetes.…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Distigmine bromide (distigmine) is a carbamate group reversible cholinesterase (ChE) inhibitor that was chemically synthetized by Schmid et al in the 1950s [1][2][3] . Although the primary clinical indication for distigmine is its involvement in the treatment of myasthenia gravis [4][5][6] , in Japan, it is also used to treat glaucoma [7][8][9][10] and underactive bladder [11][12][13][14][15][16][17] .…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…1). Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder.…”
mentioning
confidence: 99%
“…Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder. [4][5][6][7][8] The effectiveness and usefulness of distigmine for underactive bladder treatment have been shown in many clinical studies.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…It and other carbamate ChE inhibitors have been used to treat myasthenia gravis in Asia, the Middle East, and Europe. [2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968.…”
Section: Introduction
mentioning
confidence: 99%
“…[2][3][4][5] Distigmine has also been used to treat glaucoma in Japan. [6][7][8] Distigmine has also been applied as a remedy for dysuria in Japan since its release there in 1968. It was reported that distigmine has a therapeutic effect on neurogenically underactive bladder caused by surgery, spinal cord injury, and chronic diseases such as diabetes.…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Distigmine bromide (distigmine) is a carbamate group reversible cholinesterase (ChE) inhibitor that was chemically synthetized by Schmid et al in the 1950s [1][2][3] . Although the primary clinical indication for distigmine is its involvement in the treatment of myasthenia gravis [4][5][6] , in Japan, it is also used to treat glaucoma [7][8][9][10] and underactive bladder [11][12][13][14][15][16][17] .…”
Section: Introduction
mentioning
confidence: 99%